Back to Blog
Bob hugin abortion7/27/2023 ![]() ![]() ![]() In the past five years, he also served as a Director of Allergan plc, Danaher Corporation, and The Medicines Company. and Biohaven Pharmaceutical Holding Company Ltd. ![]() One of the Foundation’s central initiatives involves exploring the intersections between focused ultrasound and cancer immunotherapy, and Bob’s expertise in this space will be invaluable.”īob is currently a Director of the Parker Institute for Cancer Immunotherapy and Chair of The Darden School Foundation at the University of Virginia. “His transformational leadership in the biopharmaceutical industry, deep knowledge, and global relationships will help the Foundation propel its vision of improving the lives of millions of people around the world with a variety of serious medical disorders. “We are pleased to welcome Bob among our exceptional group of Council members,” said Foundation Chairman Neal F. Celgene was ultimately acquired by Bristol-Myers Squibb in 2019. The Foundation is pleased to welcome Bob Hugin to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide strategic advice and assist with building awareness, establishing relationships, and raising funds.īob previously served as the Chairman and Chief Executive Officer of Celgene Corporation, where he led the strategic growth and global expansion of the biopharmaceutical anticancer company for nearly 20 years. The Council is a group of goodwill ambassadors who provide strategic advice, assist with raising funds, and build awareness.Bob Hugin brings 20 years of experience in strategic growth and global expansion at a leading biopharmaceutical anticancer company. ![]()
0 Comments
Read More
Leave a Reply. |